logo-loader

Seelos Therapeutics rings the Nasdaq opening bell

Published: 16:53 12 Aug 2019 EDT

Seelos Therapeutics Inc (NASDAQ: SEEL) CEO Dr Raj Mehra caught up with Proactive after the clinical-stage biopharmaceutical rung the Nasdaq Stock Market opening bell in Times Square, New York.

Dr. Mehra says since listing on the exchange in January, the small company has achieved an 'incredible feat' by laying the groundwork to potentially be engaging in a pivotal study to treat orphan diseases and proof-of-concept studies to prevent and treat suicide and depression. 

Seelos Therapeutics receives grant money from research foundation to treat...

Team San Sanfilippo Foundation representatives told Proactive Investors the nonprofit medical research foundation has contributed grant money towards New York-based biotech Seelos Therapeutics Inc's (NASDAQ:SEEL) upcoming clinical study to treat Sanfillipo Syndrome. Team San Filippo...

on 07/15/2019